Edition:
United States

Chemours Co (CC.N)

CC.N on New York Stock Exchange

50.08USD
20 Feb 2018
Change (% chg)

$1.24 (+2.54%)
Prev Close
$48.84
Open
$48.80
Day's High
$50.52
Day's Low
$48.75
Volume
391,828
Avg. Vol
574,492
52-wk High
$58.07
52-wk Low
$32.18

Latest Key Developments (Source: Significant Developments)

The Chemours Q4 Earnings Per Share $1.19
Wednesday, 14 Feb 2018 04:15pm EST 

Feb 14 (Reuters) - Chemours Co ::THE CHEMOURS COMPANY REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS; ROBUST PERFORMANCE ACROSS ALL SEGMENTS AND KEY FINANCIAL METRICS.Q4 EARNINGS PER SHARE $1.19.Q4 SALES ROSE 19 PERCENT TO $1.6 BILLION.Q4 ADJUSTED EARNINGS PER SHARE $1.19.EXPECTING HIGHER EPS AND FREE CASH FLOW FROM IMPACT OF TAX REFORM, ON REAFFIRMED 2018 ADJUSTED EBITDA OUTLOOK.EXPECTS TO DELIVER 2018 ADJUSTED EBITDA WITHIN A RANGE OF $1.7 TO $1.85 BILLION.2018 ADJUSTED EPS IS NOW EXPECTED TO BE WITHIN A RANGE OF $4.95 TO $5.60.2018 FREE CASH FLOW IS EXPECTED TO BE GREATER THAN $600 MILLION..Q4 EARNINGS PER SHARE VIEW $0.97, REVENUE VIEW $1.55 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Univar And Chemours Reach Exclusive Distribution Agreement
Tuesday, 13 Feb 2018 06:00am EST 

Feb 13 (Reuters) - Chemours Co ::UNIVAR AND CHEMOURS REACH EXCLUSIVE DISTRIBUTION AGREEMENT IN USA FOR HYDROCHLORIC ACID.UNIVAR INC - ‍EXCLUSIVE DISTRIBUTION AGREEMENT WITH CHEMOURS COMPANY FOR HYDROCHLORIC ACID PRODUCED AT CHEMOURS' PARKERSBURG, WEST VIRGINIA, PLANT​.  Full Article

Chemours Updates 2017 Forecast, Provides 2018 Outlook, 2020 Key Financial Targets
Friday, 1 Dec 2017 11:25am EST 

Dec 1 (Reuters) - Chemours Co ::THE CHEMOURS COMPANY HOSTS FIRST INVESTOR DAY.CHEMOURS CO - BOARD OF DIRECTORS AUTHORIZED A $500 MILLION SHARE REPURCHASE PLAN.CHEMOURS CO - 2018 ‍ ADJUSTED EBITDA EXPECTED TO BE BETWEEN $1.7 AND $1.85 BILLION​.CHEMOURS CO - UNVEIL NEW CAPITAL ALLOCATION STRATEGY, WHICH IS EXPECTED TO RETURN NEARLY $900 MILLION TO SHAREHOLDERS OVER NEXT THREE YEARS.CHEMOURS CO - EXPECT TO INCREASE 2018 FREE CASH FLOW TO BE WITHIN RANGE OF $500 TO $600 MILLION, EVEN AFTER INVESTING IN TWO NEW MANUFACTURING FACILITIES.CHEMOURS - BOARD APPROVED Q1 CASH DIVIDEND OF $0.17 PER SHARE, AN INCREASE OF $0.14 PER SHARE FROM PREVIOUS LEVEL.CHEMOURS CO - EXPECTED TO GENERATE CUMULATIVE FREE CASH FLOW WITHIN A RANGE OF $2.0 BILLION AND $2.75 BILLION THROUGH 2020.CHEMOURS CO - $500 MILLION SHARE REPURCHASE PLAN EXTENDS THROUGH END OF 2020.CHEMOURS CO - SEES FULL-YEAR 2017 ADJUSTED EBITDA OF APPROXIMATELY $1.4 BILLION.CHEMOURS CO - EXPECT TO GROW ADJUSTED EPS BY 15 PERCENT OR GREATER THROUGH 2020 ON A COMPOUNDED ANNUAL BASIS OVER 2017.CHEMOURS - DEMAND FOR TI-PURE TITANIUM DIOXIDE, OPTEON REFRIGERANTS, FLUOROPOLYMERS AND CHEMICAL SOLUTIONS PRODUCTS CONTINUE TO DRIVE CO'S RESULTS.CHEMOURS CO - EXPECT TO CONTINUE TO GENERATE A RETURN ON INVESTED CAPITAL IN EXCESS OF 30 PERCENT & CO POISED FOR GROWTH THROUGH 2020 AND BEYOND.  Full Article

The Chemours Company reports third quarter results
Thursday, 2 Nov 2017 04:15pm EDT 

Nov 2 (Reuters) - Chemours Co :The Chemours Company reports third quarter results.Q3 earnings per share $1.08.Q3 sales $1.6 billion versus I/B/E/S view $1.59 billion.Q3 earnings per share view $1.04 -- Thomson Reuters I/B/E/S.Q3 adjusted earnings per share $1.12.Chemours Co - ‍full-year outlook reaffirmed​.FY2017 earnings per share view $3.57, revenue view $6.13 billion -- Thomson Reuters I/B/E/S.  Full Article

UTR partners with Chemours to develop anode material
Wednesday, 25 Oct 2017 09:07pm EDT 

Oct 26 (Reuters) - Ultracharge Ltd :Co ‍entered into agreement with Chemours to jointly develop anode material.  Full Article

Honeywell seeks rehearing of D.C. circuit court decision regarding EPA's Snap program
Friday, 22 Sep 2017 04:48pm EDT 

Sept 22 (Reuters) - Honeywell International Inc :Honeywell seeks rehearing of D.C. circuit court decision regarding EPA's Snap program.Honeywell - Co and Chemours filed a petition for rehearing of August D.C. circuit court of appeals' ruling regarding EPA's snap program​.  Full Article

Chemours responds to EPA 2015 ruling to regulate HFCs
Wednesday, 9 Aug 2017 06:17am EDT 

Aug 9 (Reuters) - Chemours Co ::Chemours responds to EPA 2015 ruling to regulate HFCs.Company is currently reviewing court's ruling and assessing its options which could include an appeal of this ruling.Chemours Co - co "‍expresses its disappointment" with decision by U.S. Court Of Appeals regarding EPA's new alternatives policy program rule 20​.Chemours Co - "‍supports" global frame-work of climate change regulations and incentives already in place​.  Full Article

The Chemours Company Q2 earnings per share $0.84
Wednesday, 2 Aug 2017 04:15pm EDT 

Aug 2 (Reuters) - Chemours Co :The Chemours Company reports strong second quarter results and increases full-year 2017 outlook.Q2 earnings per share $0.84.Q2 sales $1.6 billion versus I/B/E/S view $1.49 billion.Q2 earnings per share view $0.85 -- Thomson Reuters I/B/E/S.Q2 adjusted earnings per share $0.87.Chemours Co - expect to deliver 2017 adjusted EBITDA within a range of $1.3 to $1.4 billion.Chemours Co - expect 2017 free cash flow to be approximately breakeven, including anticipated payment for PFOA MDL settlement.  Full Article

Chemours sees 2017 adjusted EBITDA above $1.25 bln
Wednesday, 28 Jun 2017 06:30am EDT 

June 28 (Reuters) - Chemours Co :Chemours Co - sees 2017 adjusted EBITDA above $1.25 billion.Chemours Co - ‍2017 adjusted EBITDA guidance is excluding expected $335 million payment regarding PFOA litigation - SEC filing​.  Full Article

The Chemours Company announces pricing of $500,000,000 of senior notes due 2027
Tuesday, 9 May 2017 05:22pm EDT 

May 9 (Reuters) - Chemours Co ::The Chemours Company announces pricing of $500,000,000 of senior notes due 2027.Says pricing of offering of $500 million in principal amount of 5.375% senior notes due 2027 at public offering price of 99.051% of principal amount.  Full Article

BRIEF-The Chemours Q4 Earnings Per Share $1.19

* THE CHEMOURS COMPANY REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS; ROBUST PERFORMANCE ACROSS ALL SEGMENTS AND KEY FINANCIAL METRICS